Cargando…

An Update on Treatment of Drug-Induced Liver Injury

Drug-induced liver injury (DILI) has been linked to more than 1,000 medications and remains the most common cause of acute liver failure in the United States. Here, we review the most current literature regarding treatment and make recommendations for the management of this relatively common disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giordano, Christin, Rivas, John, Zervos, Xaralambos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Ltd 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521262/ https://www.ncbi.nlm.nih.gov/pubmed/26356645 http://dx.doi.org/10.14218/JCTH.2014.00005

Ejemplares similares

RUCAM in Drug and Herb Induced Liver Injury: The Update
por: Danan, Gaby, et al.
Publicado: (2015)

Benign course of residual inflammation at end of treatment of liver transplant recipients after sofosbuvir based therapy
por: Ismail, Bahaaeldeen, et al.
Publicado: (2022)

COVID-19 in liver transplant patients: Impact and considerations
por: Khazaaleh, Shrouq, et al.
Publicado: (2023)

Update on Advances in Research on Idiosyncratic Drug-Induced Liver Injury
por: Kim, Seung-Hyun, et al.
Publicado: (2016)

From hepatitis A to E: A critical review of viral hepatitis
por: Castaneda, Daniel, et al.
Publicado: (2021)

Managing liver transplantation during the COVID-19 pandemic: A survey among transplant centers in the Southeast United States
por: Gonzalez, Adalberto Jose, et al.
Publicado: (2021)

Epidemiology and Management of Drug-induced Liver Injury: Importance of the Updated RUCAM
por: Kobayashi, Takashi, et al.
Publicado: (2023)

Treatment of Drug-Induced Liver Injury
por: Teschke, Rolf
Publicado: (2022)

Gut microbiota and drug-induced liver injury: an update
por: Niu, Meng-Wei, et al.
Publicado: (2020)

Nasal Bridles for Securing Nasoenteric Feeding Tubes: A Review of Clinical Effectiveness and Potential Complications
por: Inayat, Faisal, et al.
Publicado: (2020)

Liver transplantation amidst the COVID-19 era: Our center’s experience
por: Khazaaleh, Shrouq, et al.
Publicado: (2023)

Chronic Drug-Induced Liver Injury: Updates and Future Challenges
por: Wang, Qiaoling, et al.
Publicado: (2021)

Herb-Induced Liver Injuries in Developing Nations: An Update
por: Amadi, Cecilia Nwadiuto, et al.
Publicado: (2018)

Drug-induced liver injury
por: Suh, Jeong Ill
Publicado: (2019)

Orthotopic Liver Transplantation in a Cirrhotic Patient With Recent COVID-19 Infection
por: Gonzalez, Adalberto, et al.
Publicado: (2021)

Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy
por: Kapila, Nikhil, et al.
Publicado: (2019)

An Immunological Perspective on the Mechanism of Drug Induced Liver Injury: Focused on Drugs for Treatment of Hepatocellular Carcinoma and Liver Transplantation
por: Lee, Soon Kyu, et al.
Publicado: (2023)

Drug-induced liver injury: present and future
por: Suk, Ki Tae, et al.
Publicado: (2012)

Drug‐Induced Liver Injury in GI Practice
por: Sandhu, Naemat, et al.
Publicado: (2020)

Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury
por: Jing, Jing, et al.
Publicado: (2017)

MicroRNAs in Drug-induced Liver Injury
por: Li, Li-Min, et al.
Publicado: (2014)

Drug-induced liver injury: the dawn of biomarkers?
por: Weiler, Stefan, et al.
Publicado: (2015)

Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM
por: Andújar-Vera, Francisco, et al.
Publicado: (2023)

Factors affecting drug-induced liver injury: antithyroid drugs as instances
por: Heidari, Reza, et al.
Publicado: (2014)

Mechanism of drug-induced liver injury and hepatoprotective effects of natural drugs
por: Zhou, Yongfeng, et al.
Publicado: (2021)

Dissecting the molecular pathophysiology of drug-induced liver injury
por: Ye, Hui, et al.
Publicado: (2018)

Immune mechanisms of idiosyncratic drug-induced liver injury
por: Mak, Alastair, et al.
Publicado: (2017)

Mechanistic insights into antiretroviral drug‐induced liver injury
por: Pillaye, Jamie N., et al.
Publicado: (2020)

Drug-induced liver injury: a comprehensive review
por: Hosack, Tom, et al.
Publicado: (2023)

Prevention and treatment of sepsis-induced acute kidney injury: an update
por: Honore, Patrick M., et al.
Publicado: (2015)

Comparison of Different Liver Test Thresholds for Drug-Induced Liver Injury: Updated RUCAM versus Other Methods
por: Yang, Hongyi, et al.
Publicado: (2019)

Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury
por: Lin, Christine, et al.
Publicado: (2016)

An Update on Laboratory Diagnosis of Liver Inherited Diseases
por: Zarrilli, Federica, et al.
Publicado: (2013)

Anabolic androgenic steroid-induced liver injury: An update
por: Petrovic, Ana, et al.
Publicado: (2022)

Drug-Induced Liver Injury: Pattern Recognition and Future Directions
por: Haque, Tanvir, et al.
Publicado: (2016)

Drug-induced liver injury: Do we know everything?
por: Alempijevic, Tamara, et al.
Publicado: (2017)

Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges
por: Jee, Alison, et al.
Publicado: (2021)

Applications of In Silico Models to Predict Drug-Induced Liver Injury
por: Lin, Jiaying, et al.
Publicado: (2022)

In Vitro Models for Studying Chronic Drug-Induced Liver Injury
por: Donato, M. Teresa, et al.
Publicado: (2022)

Drug-Induced Liver Injury
por: Almario, Eileen E. N., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_panufk0va1ldipcqmtvmvd6ubg